Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma

Authors

Keywords

Journal

Volume 38, Issue 15, Pages 1693-1701

Publisher

American Society of Clinical Oncology (ASCO)

Online

2020-03-25

DOI

10.1200/jco.19.02492

Discuss science. Find collaborators. Network.

Join a conversation

Explore over 38,000 international journals covering a vast array of academic fields.